I agree, he didn’t create any issue for the trial; serious or minor. There is no way he would compromise a potentially breakthrough trial by speaking on a news program. He knows better.
Steady, don’t you believe Anavex “ok’d” the news segment prior to it airing? Or do you think it is an independent announcement from trial investigators, of which Anavex had no role whatsoever?
Not likely the case for placebo patients coming off the blinded trial. I'm willing to bet those placebo patients aren't having many good days before entering the OLE.
Market Data 
Markets 
AI
